Top Rule Breakers Seek Innovation
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 9 hours ago
0mins
Should l Buy ORCL?
Source: Fool
- Vertex Drug Trial Success: Vertex Pharmaceuticals (VRTX) rose over 5% after the closing bell due to positive trial data from Povetacicept, enhancing the likelihood of a potential accelerated FDA approval filing, which is expected to further boost the company's stock performance, surpassing a 33% increase over the S&P 500 since February 2022.
- Hewlett Packard's Strong Earnings: Hewlett Packard (HPE) gained over 1% thanks to a 380% surge in Data Center Networking sales and an upgraded group revenue forecast, indicating robust growth potential in the market that may attract more investor interest.
- Casey's and Vail Resorts Earnings Pressure: Casey's General Stores (CASY) dropped about 2% ahead of the opening bell due to only a 0.5% revenue increase, while Vail Resorts (MTN) fell after reporting a 5% quarterly revenue drop, with the CEO citing weather impacts, highlighting challenges faced by the industry.
- BioNTech Faces Losses: BioNTech (BNTX) fell over 14% ahead of the opening bell as it reported an annual net loss nearly double that of the previous year and announced plans for co-founders to create an independent company focusing on next-generation mRNA innovations, which may affect its future market performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ORCL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ORCL
Wall Street analysts forecast ORCL stock price to rise
34 Analyst Rating
25 Buy
9 Hold
0 Sell
Moderate Buy
Current: 151.560
Low
180.00
Averages
309.59
High
400.00
Current: 151.560
Low
180.00
Averages
309.59
High
400.00
About ORCL
Oracle Corporation offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. The Company operates through three businesses: cloud and license, hardware and service. Its cloud and license business is engaged in the sale, marketing and delivery of its enterprise applications and infrastructure technologies through cloud and on-premise deployment models including its cloud services and license support offerings, and its cloud license and on-premise license offerings. Its hardware business provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management and other hardware-related software to support diverse IT environments. Its services business provides services to customers and partners to help maximize the performance of their investments in Oracle applications and infrastructure technologies.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Revenue Growth Expectations: Analysts anticipate Oracle's Q3 revenue to reach $16.9 billion, a 19% increase from $14.13 billion in the same quarter last year, indicating the company's ongoing expansion in the cloud computing sector and strong market demand.
- Strong Profitability: Despite Oracle missing revenue estimates in 8 of the last 10 quarters, its profit performance has been robust, exceeding earnings expectations in the last three quarters, demonstrating effective strategies in cost control and profit enhancement.
- Cloud Services Contract: Oracle secured a deal with the Centers for Medicare & Medicaid Services to migrate critical systems to its cloud platform, further solidifying its position in the government cloud services market while adhering to strict federal security standards.
- Defense Contract Expansion: Oracle won an $88 million task order from the U.S. Air Force to provide cloud services for highly sensitive workloads, showcasing the company's competitiveness and market confidence in securing government and enterprise infrastructure contracts.
See More
- Data Center Progress: Oracle confirmed that its flagship AI data center in Abilene, Texas, is operational with 200MW, and despite challenges with the expansion plans alongside OpenAI, the company asserts that progress is on track, alleviating market concerns about the future of its data centers.
- Financial Expectations: Analysts anticipate Oracle's third-quarter revenue to rise nearly 20% to $16.9 billion, marking the best growth rate in three years, although the company faces increasing debt and risks associated with reliance on a small group of customers.
- Debt Pressure: Oracle is piling on massive debt to fund new data center builds, planning to raise up to $50 billion this year through debt and equity financing, which has raised investor concerns, particularly given the company's performance is heavily reliant on a single customer.
- Market Reaction: Despite Oracle's stock price dropping over 53% since September 10, 32 out of 43 analysts still rate it as 'Buy' or higher, indicating cautious optimism in the market regarding its future growth, especially in the context of AI-driven revenue acceleration.
See More
- Earnings Beat: Oracle reported a non-GAAP EPS of $1.79 for Q3, exceeding estimates by $0.10, which underscores the company's robust profitability and strengthens market confidence in its financial health.
- Significant Revenue Growth: The company achieved $17.19 billion in revenue for Q3, surpassing market expectations by $280 million, reflecting sustained demand in cloud computing and software services, driving strong overall business performance.
- Capital Funding Plan Update: Oracle updated its capital funding plans in the earnings report, indicating continued investments in technological innovation and market expansion to support future growth strategies, enhancing its position in the competitive tech industry.
- Attractive Dividend Yield: Oracle's preferred shares offer a 6.6% yield, appealing to income-seeking investors, which further enhances the company's attractiveness in the capital markets and may promote long-term stock price appreciation.
See More
- Strong Performance: Oracle reported a non-GAAP EPS of $1.79, beating estimates by $0.10, which highlights the company's robust profitability amid ongoing growth, further solidifying its leadership in the cloud computing market.
- Revenue Growth: The company achieved Q3 revenue of $17.19 billion, exceeding market expectations by $280 million, reflecting strong demand in its cloud services and software business, which is expected to drive sustained growth in the future.
- Capital Funding Plan Update: Oracle updated its capital funding plans, indicating that the company will continue to invest in technological innovation and market expansion to support its long-term growth strategy and enhance its competitive edge.
- Positive Market Reaction: Following the earnings beat, Oracle's stock price surged, increasing market confidence in its future performance, which may attract more investor attention and further drive stock price appreciation.
See More
- Strong Earnings Beat: Oracle reported adjusted earnings of $1.79 per share for the third quarter ending February 28, with revenue rising 22% year-over-year to $17.19 billion, surpassing Wall Street's expectations of $1.70 and $16.89 billion, indicating robust profitability and market demand.
- Significant Cloud Growth: Cloud revenue reached $8.9 billion, up 44% year-over-year, exceeding the $8.84 billion estimate, with infrastructure revenue soaring 84% to $4.9 billion and application revenue rising 11% to $4 billion, showcasing Oracle's strong performance in the cloud computing sector.
- Optimistic Future Outlook: Oracle expects fourth-quarter fiscal 2026 revenue to grow between $18.93 billion and $19.24 billion, reflecting an 18% to 20% increase, with cloud revenue anticipated to grow between 44% and 48%, and adjusted earnings projected between $1.92 and $1.96 per share, all above analyst expectations, demonstrating confidence in future growth.
- Capital Spending Update: Oracle has raised $30 billion of the $50 billion it aimed for through debt and equity markets, with a record oversubscribed order book, indicating strong investor confidence in its financial health and further strengthening its capital structure.
See More
- Stake Sale Overview: On February 17, 2026, BLKBRD Asset Management disclosed it sold all 318,666 shares of Hims & Hers Health, with an estimated transaction value of $18.07 million, reflecting a complete exit from its position during the fourth quarter.
- Impact on Asset Management: This sale reduced Hims & Hers' stake from 5% to 0%, indicating a significant loss of confidence from BLKBRD, which could negatively influence market perceptions of Hims & Hers.
- Stock Performance: As of February 16, 2026, Hims & Hers shares were priced at $16.30, down 72.46% over the past year, underperforming the S&P 500 by 84.25 percentage points, highlighting severe competitive challenges.
- Future Outlook: Although Hims & Hers recently announced a new partnership with Novo Nordisk that may provide a short-term stock rebound, ongoing market pressures and competitive challenges suggest that investors should carefully assess the company's long-term prospects.
See More










